Jiudian Pharmaceutical: Progress Announcement on Providing Guarantees for Wholly-owned Subsidiaries
Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20240912
Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20240909
Jiudian Pharmaceutical: Announcement on Jiudian Transfer 02 Interest Payment
Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20240903
Jiudian Pharmaceutical: Announcement on the Company\'s Obtaining a Drug Registration Certificate
Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20240825
Hunan Jiudian Pharmaceutical: Internal Control System (Revised August 2024)
Hunan Jiudian Pharmaceutical: Announcement of the Supervisory Board's resolution.
Hunan Jiudian Pharmaceutical: Western Securities Co., Ltd. Interim Tracking Report for the first half of 2024.
Hunan Jiudian Pharmaceutical: Board of directors resolution announcement.
Hunan Jiudian Pharmaceutical: Opinion on the verification of the company's joint investment with professional investment institutions and related transactions by Western Securities Co., Ltd.
Hunan Jiudian Pharmaceutical: Summary Table of Non-Operating Funds Used and Other Related Fund Transactions for the First Half of 2024.
Hunan Jiudian Pharmaceutical: Opinion on the verification of the progress of the company's adjustment of the investment project plan for part of the fund raising by Western Securities Co., Ltd.
Hunan Jiudian Pharmaceutical: Announcement regarding the adjustment of the investment project plan progress of part of the raised funds.
Hunan Jiudian Pharmaceutical: Special report on the storage and use of funds raised in the first half of 2024.
Hunan Jiudian Pharmaceutical: Internal audit system (revised in August 2024).
Hunan Jiudian Pharmaceutical: Summary of Half-Year Report in 2024.
Hunan Jiudian Pharmaceutical: Announcement regarding investment and related party transactions with professional investment institutions.
Hunan Jiudian Pharmaceutical: Half-year report for the year 2024.
No Data
No Data